RESEARCH ON THE CONCENTRATION CHARACTERISTICS AND VALUE OF NGAL IN THE PROGNOSIS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-ST-ELEVATION MYOCARDIAL INFARCTION AT VINH LONG GENERAL HOSPITAL IN 2024-2025

Luận Lê Công, Truyền Ngô Văn, Phen Phan Văn

Main Article Content

Abstract

Objectives: Survey of concentration characteristics and value of NGAL in predicting major adverse cardiovascular events in patients with non-ST-elevation myocardial infarction. Materials and methods: A cross-sectional descriptive study on patients admitted to Vinh Long General Hospital from May 2024 to March 2025. Patients were tested for NGAL concentration and major adverse cardiovascular events were recorded three months after discharge. Results: Of the total 80 patients, 57.5% were male, 75.0% had underlying hypertension. NGAL concentration was 67.88 ± 27.65 ng/mL, hypertensive patients had higher NGAL than non-hypertensive patients with 82.06 ± 29.50 ng/mL compared to 65.48 ± 26.83 ng/mL. The rate of major adverse cardiovascular events was 28.7%. The NGAL value at the cut-off point of 84.45 ng/mL had a sensitivity of 60.9% and a specificity of 87.7% in predicting major adverse cardiovascular events. Conclusion: In patients with non-ST-elevation myocardial infarction, NGAL values ​​at admission have the ability to predict the occurrence of major adverse cardiovascular events at three months after discharge.

Article Details

References

1. Byrne RA, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology. European Heart Journal: Acute Cardiovascular Care. 2023. 13(1), p. 55-161.
2. Chen WS. Proportion and in-hospital mortality of hospitalized patients with ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction from 2007 to 2018. Academic Journal of Second Military Medical University. 2020, p. 1053-61.
3. Nassar DK. Neutrophil gelatinase-associated lipocalin role in diagnosis of complications of liver cirrhosis. Egyptian Journal of Medical Microbiology. 2021. 30(2), p. 21-25.
4. Nymo SH, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) concentration is independently associated with mortality in patients with acute coronary syndrome. International journal of cardiology. 2018. 262, p. 79-84.
5. Peng W, et al. Prognostic value of neutrophil gelatinase-associated lipocalin and glycosylated hemoglobin for non-ST-segment elevation myocardial infarction patients with single concomitant chronic total occlusion following primary percutaneous coronary intervention: A prospective observational study. Medicine. 2019. 98(39), p. e16982.
6. Liu H, et al. Neutrophil gelatinase-associated lipocalin contributes to increased risk of cardiovascular death after acute coronary syndrome. International Journal of General Medicine. 2021, p. 4887-4895.